SLC2A10
Solute carrier family 2, facilitated glucose transporter member 10
Also known as: GLUT-10, GLUT10, GTR10_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O95528
- Gene
- SLC2A10
- Ensembl
- ENSG00000197496
- Chromosome
- 20
- Canonical length
- 541 aa
- Protein class
- Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters
- Subcellular location
- Cytosol
OverviewNCBI Gene
This gene encodes a member of the class III facilitative glucose transporter family. The encoded protein plays a role in regulation of glucose homeostasis. Mutations in this gene have been associated with arterial tortuosity syndrome.[provided by RefSeq, Dec 2009]
Canonical amino-acid sequenceUniProt
541 residues, UniProt reviewed canonical sequence.
>O95528|SLC2A10
1 MGHSPPVLPL CASVSLLGGL TFGYELAVIS GALLPLQLDF GLSCLEQEFL VGSLLLGALL
61 ASLVGGFLID CYGRKQAILG SNLVLLAGSL TLGLAGSLAW LVLGRAVVGF AISLSSMACC
121 IYVSELVGPR QRGVLVSLYE AGITVGILLS YALNYALAGT PWGWRHMFGW ATAPAVLQSL
181 SLLFLPAGTD ETATHKDLIP LQGGEAPKLG PGRPRYSFLD LFRARDNMRG RTTVGLGLVL
241 FQQLTGQPNV LCYASTIFSS VGFHGGSSAV LASVGLGAVK VAATLTAMGL VDRAGRRALL
301 LAGCALMALS VSGIGLVSFA VPMDSGPSCL AVPNATGQTG LPGDSGLLQD SSLPPIPRTN
361 EDQREPILST AKKTKPHPRS GDPSAPPRLA LSSALPGPPL PARGHALLRW TALLCLMVFV
421 SAFSFGFGPV TWLVLSEIYP VEIRGRAFAF CNSFNWAANL FISLSFLDLI GTIGLSWTFL
481 LYGLTAVLGL GFIYLFVPET KGQSLAEIDQ QFQKRRFTLS FGHRQNSTGI PYSRIEISAA
541 SLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SLC2A10 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 12
- Mean surface accessibility (rSASA)
- 0.33
- Highest tissue expression
- 40 nTPM
Expression across tissuesHPA
Tissue
- liver: 40 nTPM
- prostate: 29 nTPM
- salivary gland: 24 nTPM
- stomach: 22 nTPM
- choroid plexus: 19 nTPM
- parathyroid gland: 18 nTPM
Single-cell type
- prostatic glandular cells: 102 nCPM
- goblet cells: 84 nCPM
- hepatocytes: 60 nCPM
- foveolar cells: 58 nCPM
- breast hormone-responsive cells: 53 nCPM
- respiratory secretory cells: 51 nCPM
Immune cell
- basophil: 21 nTPM
- NK-cell: 0.2 nTPM
- neutrophil: 0.1 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
Brain region
- choroid plexus: 39 nTPM
- medulla oblongata: 9.8 nTPM
- midbrain: 8.9 nTPM
- thalamus: 7.4 nTPM
- basal ganglia: 7.2 nTPM
- amygdala: 7.1 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about SLC2A10.
Disease | AllUniProt
Conditions SLC2A10 is implicated in, by any mechanism.
- Arterial tortuosity syndrome (ATORS) MIM:208050
Disease | GeneticClinVar
55 pathogenic / likely-pathogenic of 747 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Arterial tortuosity syndrome
- Familial thoracic aortic aneurysm and aortic dissection
- Familial aortopathy
- SLC2A10-related disorder
- Cardiovascular phenotype
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.39
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.75
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- artery development
- cell redox homeostasis
- circulatory system development
- D-glucose import across plasma membrane
- D-glucose transmembrane transport
- dehydroascorbic acid transport
- embryonic skeletal joint development
- galactose transmembrane transport
- hexose transmembrane transport
- negative regulation of gene expression
- negative regulation of integrin-mediated signaling pathway
- negative regulation of proteoglycan biosynthetic process
- negative regulation of transforming growth factor beta receptor signaling pathway
- positive regulation of gene expression
- positive regulation of proteoglycan biosynthetic process
- positive regulation of transforming growth factor beta receptor signaling pathway
- regulation of extracellular matrix organization
- skin development
- transport across blood-brain barrier
- negative regulation of connective tissue growth factor production
Molecular functions
- carbohydrate:proton symporter activity
- D-glucose transmembrane transporter activity
- dehydroascorbic acid transmembrane transporter activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SLC2A10 as an antibody target. Whether an autoantibody or antibody against SLC2A10 could matter depends on whether native SLC2A10 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SLC2A10 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label SLC2A10 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...